GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1–2 September 2014

By Alexander Heifetz, Gebhard F.X. Schertler1, Roland Seifert, Christopher G. Tate, Patrick M. Sexton, Vsevolod V. Gurevich, Daniel Fourmy, Vadim Cherezov2, Fiona H. Marshall, R. Ian Storer, Isabel Moraes, Irina G. Tikhonova, Christofer S. Tautermann, Peter Hunt, Tom Ceska, Simon Hodgson, Mike J. Bodkin, Shweta Singh, Richard J. Law, Philip C. Biggin

1. ETH Zürich / Paul Scherrer Institut, Villigen Switzerland 2. Bridge Institute - University of Southern California

See also

No results found.

Published on

Type

journal-article

Author

Alexander Heifetz and Gebhard F. X. Schertler and Roland Seifert and Christopher G. Tate and Patrick M. Sexton and Vsevolod V. Gurevich and Daniel Fourmy and Vadim Cherezov and Fiona H. Marshall and R. Ian Storer and Isabel Moraes and Irina G. Tikhonova and Christofer S. Tautermann and Peter Hunt and Tom Ceska and Simon Hodgson and Mike J. Bodkin and Shweta Singh and Richard J. Law and Philip C. Biggin

Citation

Heifetz, A. et al., 2015. GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1–2 September 2014. Naunyn-Schmiedeberg’s Arch Pharmacol, 388(8), pp.883–903. Available at: http://dx.doi.org/10.1007/s00210-015-1111-8.

DOI